BTG3 and rheumatic disorder: Of the two COVID-19 patients with a history of rheumatic disease (#1 and 16), one patient (#1) showed high ANA titer in IIF (1:1000), while the other patient (#16) had detectable anti-Nucleosome/anti-dsDNA antibodies.